RNAIII-inhibiting peptide(TFA)

RNAIII-inhibiting peptide(TFA)

• CAS Number: 2703745-76-8
• UNSPSC Description: RNAIII-inhibiting peptide(TFA) is a potent inhibitor of Staphylococcus aureus, effective in the diseases such as cellulitis, keratitis, septic arthritis, osteomylitis and mastitis.
• Target Antigen: Bacterial
• Type: Peptides
• Related Pathways: Anti-infection
• Applications: COVID-19-immunoregulation
• Field of Research: Infection
• Assay Protocol: https://www.medchemexpress.com/RNAIII-inhibiting_peptide_TFA_.html
• Purity: 99.19
• Solubility: DMSO : ≥ 150 mg/mL|H2O : 100 mg/mL (ultrasonic)
• Smiles: FC(F)(F)C(O)=O.O=C(N[C@@H](CO)C(N1[C@@H](CCC1)C(N[C@@H](CC2=CNC3=CC=CC=C23)C(N[C@@H]([C@H](O)C)C(N[C@@H](CC(N)=O)C(N[C@@H](CC4=CC=CC=C4)C(N)=O)=O)=O)=O)=O)=O)[C@H](CC5=CC=C(C=C5)O)N
• Molecular Weight: 1027.01
• References & Citations: [1]Gov Y, et al. RNAIII inhibiting peptide (RIP), a global inhibitor of Staphylococcus aureus pathogenesis: structure and function analysis. Peptides. 2001 Oct;22(10):1609-20.|[2]Giacometti A, et al. RNAIII-inhibiting peptide improves efficacy of clinically used antibiotics in a murine model of staphylococcal sepsis. Peptides. 2005 Feb;26(2):169-75.
• Shipping Conditions: Blue Ice
• Storage Conditions: -80°C, 2 years; -20°C, 1 year (Powder, sealed storage, away from moisture)
• Clinical Information: No Development Reported